Beauty Health (SKIN) Stock Price, News & Analysis

Company Overview

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth. Each brand combines science-backed ingredients or technologies with curated routines to drive consumer engagement and loyalty.

Products under the Beauty Health umbrella are sold direct to consumers via branded websites and digital channels, as well as through major department stores, specialty beauty retailers, professional skin care outlets and select international distributors. This omnichannel approach enables the company to reach customers in North America, Europe and the Asia-Pacific region, while also leveraging online communities and social marketing to strengthen brand recognition and consumer education.

Beauty Health emerged as a public company in July 2021 through a business combination with a special purpose acquisition company, commencing trading on the NASDAQ under the ticker SKIN. Since its listing, the company has focused on accelerating brand innovation, expanding its direct-to-consumer capabilities and exploring strategic partnerships to drive long-term growth in the rapidly evolving global beauty and wellness market.

Key Stats

• Today's Range: $0.89 to $0.93
• 50-Day Range: $0.80 to $1.27
• 52-Week Range: $0.76 to $2.69
• Volume: 775,985 shs
• Average Volume: 654,670 shs
• Market Capitalization: $114.99 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.32
• Consensus Rating: Hold

Beauty Health Stock Analysis - MarketRank™

Beauty Health scored higher than 65% of companies evaluated by MarketBeat, and ranked 259th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Hold

Consensus Rating

Beauty Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 6 hold ratings, and 1 sell rating.

Upside Potential

Beauty Health has a consensus price target of $2.32, representing about 158.2% upside from its current price of $0.90.

Amount of Analyst Coverage

Beauty Health has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Beauty Health are expected to grow in the coming year, from ($0.18) to ($0.12) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Beauty Health is -4.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Beauty Health is -4.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Beauty Health has a P/B Ratio of 1.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for SKIN.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Beauty Health does not currently pay a dividend.

Dividend Growth

Beauty Health does not have a long track record of dividend growth.

News and Social Media

• Score: 4.4 / 5
• News Sentiment: 1.06

News Sentiment

Beauty Health has a news sentiment score of 1.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for Beauty Health this week, compared to 10 articles on an average week.

Search Interest

3 people have searched for SKIN on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Beauty Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Beauty Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

40.30% of the stock of Beauty Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

93.26% of the stock of Beauty Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SKIN Stock Analysis - Frequently Asked Questions

How have SKIN shares performed this year?

Beauty Health's stock was trading at $1.39 on January 1st, 2026. Since then, SKIN shares have decreased by 35.3% and is now trading at $0.8987.

How were Beauty Health's earnings last quarter?

The Beauty Health Company (NASDAQ:SKIN) issued its quarterly earnings data on Thursday, March, 12th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. The business had revenue of $82.37 million for the quarter, compared to analyst estimates of $78.07 million. Beauty Health had a negative trailing twelve-month return on equity of 15.40% and a negative net margin of 3.16%.
Read the conference call transcript.

Who are Beauty Health's major shareholders?

Beauty Health's top institutional shareholders include Capricorn Fund Managers Ltd (15.19%), Bank of New York Mellon Corp (0.23%) and Diversified Trust Co (0.02%). Insiders that own company stock include Brent L Saunders, Michael P Monahan, Desiree Gruber and Doug K Schillinger.
View institutional ownership trends.

How do I buy shares of Beauty Health?

Shares of SKIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Beauty Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Beauty Health investors own include Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

• Last Earnings: 3/12/2026
• Today: 5/05/2026
• Next Earnings (Estimated): 5/07/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SKIN
• CIK: 1818093
• Web: hydrafacial.com
• Phone: 800-603-4996
• Fax: N/A
• Employees: 1,030
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Beauty Health: $2.32
• High Price Target: $4.00
• Low Price Target: $1.00
• Potential Upside/Downside: +157.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$9.52 million
• Net Margins: -3.16%
• Pretax Margin: -1.97%
• Return on Equity: -15.40%
• Return on Assets: -1.74%

Debt

• Debt-to-Equity Ratio: 3.94
• Current Ratio: 1.66
• Quick Ratio: 1.40

Sales & Book Value

• Annual Sales: $300.80 million
• Price / Sales: 0.38
• Cash Flow: $0.16 per share
• Price / Cash Flow: 5.65
• Book Value: $0.48 per share
• Price / Book: 1.88

Miscellaneous

• Outstanding Shares: 127,770,000
• Free Float: 76,280,000
• Market Cap: $114.99 million
• Optionable: Optionable
• Beta: 1.12